Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel Free GMED Stock Alerts

Globus Medical (GMED) Short Interest Ratio & Short Volume

Globus Medical logo
$85.48 +0.33 (+0.39%)
As of 03:58 PM Eastern
Compare

Globus Medical Short Interest Overview

As of July 31, 2026, Globus Medical (GMED) had a short interest of 6.89 million shares sold short, representing 6.22% of the public float. This marks a -2.58% decrease in short interest since the prior report. The short interest ratio (days to cover) is 4.9, meaning it would take 4.9 days of the average trading volume of 1.61 million shares to cover all short positions.

Current Short Interest
6,886,644 shares
Previous Short Interest
7,069,160 shares
Change Vs. Previous Month
-2.58%
Dollar Volume Sold Short
$543.96 million
Short Interest Ratio
4.9 Days to Cover
Last Record Date
July 31, 2026
Outstanding Shares
135,740,000 shares
Short Percent of Float
6.22%
Today's Trading Volume
1,085,669 shares
Average Trading Volume
1,613,449 shares
Today's Volume Vs. Average
67%
Short Selling Globus Medical?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Globus Medical and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

GMED Short Interest Over Time

GMED Days to Cover Over Time

GMED Percentage of Float Shorted Over Time

Globus Medical Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/20266,886,644 shares $543.96 million -2.6%6.2%4.89 $78.99
7/15/20267,069,160 shares $555.18 million -4.6%6.4%3.5 $78.54
6/30/20267,409,990 shares $586.54 million +35.5%6.7%3.56 $79.16
6/15/20265,469,519 shares $422.52 million +39.7%4.9%3.43 $77.25
5/29/20263,916,683 shares $321.16 million +14.7%3.5%1.93 $82.00
5/15/20263,414,228 shares $261.24 million +9.4%3.1%1.62 $76.52
4/30/20263,120,512 shares $281.36 million -5.8%2.8%3.52 $90.17
4/15/20263,313,920 shares $312.98 million +17.1%3.0%2.9 $94.45
3/31/20262,831,226 shares $244.24 million -14.1%2.6%2.86 $86.27
3/13/20263,293,919 shares $279.35 million +0.7%3.0%3.33 $84.81
2/27/20263,270,517 shares $311.98 million -30.1%3.0%2.3 $95.39
2/13/20264,675,619 shares $411.68 million +13.4%4.2%3.94 $88.05
1/30/20264,124,408 shares $374.13 million +6.4%3.8%3.74 $90.71
1/15/20263,875,375 shares $363.73 million -9.1%3.6%1.9 $93.86
12/31/20254,262,628 shares $372.51 million +4.0%3.9%3.61 $87.39
12/15/20254,097,040 shares $354.37 million -6.8%3.8%2.69 $86.50
11/28/20254,397,222 shares $400.32 million -8.9%4.0%2.55 $91.04
11/14/20254,824,835 shares $406.90 million -32.5%4.4%1.49 $84.34
10/31/20257,150,376 shares $432.64 million +12.9%6.5%5.71 $60.51
10/15/20256,330,000 shares $369.39 million +3.4%5.8%4.8 $58.36
9/30/20256,120,000 shares $350.68 million -7.1%N/A4.3 $57.30
9/15/20256,590,000 shares $383.37 million +14.4%N/A4.6 $58.18
8/31/20255,760,000 shares $352.83 million +5.9%5.2%4.1 $61.26
8/15/20255,440,000 shares $329.83 million +13.8%N/A3.9 $60.63
7/31/20254,780,000 shares $251.49 million +5.8%4.3%2.8 $52.61
7/15/20254,520,000 shares $252.49 million +4.9%N/A2.8 $55.86
6/30/20254,310,000 shares $254.20 million -7.1%3.9%2.9 $58.98
6/15/20254,640,000 shares $273.06 million -10.1%4.2%3.2 $58.85
5/31/20255,160,000 shares $305.37 million +14.4%4.7%3.4 $59.18
5/15/20254,510,000 shares $260.50 million +6.9%4.1%2.9 $57.76
4/30/20254,220,000 shares $303.04 million -0.5%N/A2.9 $71.81
4/15/20254,240,000 shares $306.49 million +28.5%3.8%3.4 $72.29
3/31/20253,300,000 shares $241.49 million +36.4%3.0%2.4 $73.18
3/15/20252,420,000 shares $172.32 million -7.6%2.2%1.9 $71.21
2/28/20252,620,000 shares $210.49 million +12.9%2.4%2.3 $80.34
2/15/20252,320,000 shares $194.86 million +6.4%2.1%2.1 $83.99
1/31/20252,180,000 shares $202.09 million -12.8%N/A1.9 $92.70
1/15/20252,500,000 shares $226.40 million +0.4%N/A2.4 $90.56
12/31/20242,490,000 shares $205.95 million +4.6%N/A2.6 $82.71
12/15/20242,380,000 shares $196.16 million -2.5%N/A2.7 $82.42
These gold assets are priced for $1,800 gold [it's over $4,000] (Ad)

Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's pullback from highs above 4000 an ounce. Yet top junior mining assets remain priced as if gold were still stuck near 1800 an ounce, a gap analyst Garrett Goggin calls the Golden Anomaly. With record cash on hand, majors may soon be forced to buy juniors to secure future production.tc pixel

See the junior gold assets majors may target next
11/30/20242,440,000 shares $208.89 million -12.5%N/A3 $85.61
11/15/20242,790,000 shares $226.27 million -2.5%N/A3.5 $81.10
10/31/20242,860,000 shares $210.32 million +0.7%N/A3.5 $73.54
10/15/20242,840,000 shares $210.30 million -16.7%N/A3.5 $74.05
9/30/20243,410,000 shares $243.95 million -3.4%N/A4.3 $71.54
9/15/20243,530,000 shares $246.22 million -19.6%N/A4.1 $69.75
8/31/20244,390,000 shares $319.15 million No ChangeN/A4.8 $72.70
8/15/20244,390,000 shares $301.99 million -9.1%N/A4.6 $68.79
7/31/20244,830,000 shares $347.86 million -29.0%N/A4.6 $72.02
7/15/20246,800,000 shares $489.87 million -5.0%N/A6.7 $72.04
6/30/20247,160,000 shares $490.39 million +4.4%N/A7 $68.49
6/15/20246,860,000 shares $450.08 million -2.6%N/A6.6 $65.61
5/31/20247,040,000 shares $472.45 million -2.0%N/A6.5 $67.11
5/15/20247,180,000 shares $463.61 million -20.1%N/A6.5 $64.57
4/30/20248,990,000 shares $447.61 million +19.7%N/A8 $49.79
4/15/20247,510,000 shares $389.09 million -3.2%N/A7.2 $51.81
3/31/20247,760,000 shares $416.25 million +32.4%N/A6.7 $53.64
3/15/20245,860,000 shares $301.26 million +2.3%N/A5.1 $51.41
2/29/20245,730,000 shares $309.36 million -0.9%N/A4.8 $53.99
2/15/20245,780,000 shares $309.40 million +8.7%N/A4.7 $53.53
1/31/20245,320,000 shares $280.66 million +55.1%N/A4.3 $52.76
1/15/20243,430,000 shares $192.83 million No ChangeN/A2.6 $56.22
12/31/20233,430,000 shares $182.78 million +0.9%N/A2.7 $53.29
12/15/20233,400,000 shares $168.44 million +6.3%N/A2.6 $49.54
11/30/20233,200,000 shares $143.74 million -13.0%N/A2.3 $44.92
11/15/20233,680,000 shares $168.58 million -7.8%N/A1.8 $45.81
10/31/20233,990,000 shares $182.38 million -6.3%N/A2 $45.71
10/15/20234,260,000 shares $226.29 million -4.1%N/A2.3 $53.12
9/30/20234,440,000 shares $220.45 million +3.0%N/A2.5 $49.65
9/15/20234,310,000 shares $215.59 million -59.2%N/A2.6 $50.02
8/31/202310,570,000 shares $572.31 million +32.6%N/A6.8 $54.15
8/15/20237,970,000 shares $455.09 million -1.5%10.3%9.3 $57.10
7/31/20238,090,000 shares $487.42 million -1.6%10.5%8.7 $60.25
7/15/20238,220,000 shares $509.23 million +3.9%10.6%7.6 $61.95
6/30/20237,910,000 shares $470.96 million +2.3%10.2%7 $59.54
6/15/20237,730,000 shares $453.98 million -3.9%10.0%6.2 $58.73
5/31/20238,040,000 shares $435.21 million +4.4%10.4%5.9 $54.13
5/15/20237,700,000 shares $436.28 million +24.0%10.0%5.3 $56.66
4/30/20236,210,000 shares $361.05 million +7.4%8.0%3.5 $58.14
4/15/20235,780,000 shares $332.58 million +13.1%7.5%3.7 $57.54
3/31/20235,110,000 shares $289.43 million +12.8%6.6%3.4 $56.64
3/15/20234,530,000 shares $237.87 million +17.1%5.9%3.4 $52.51
2/28/20233,870,000 shares $225.78 million +50.0%5.0%3.4 $58.34
2/15/20232,580,000 shares $158.57 million -47.4%3.3%2.5 $61.46
1/31/20234,900,000 shares $369.95 million +1.0%6.4%6.4 $75.50
1/15/20234,850,000 shares $360.84 million +2.1%6.3%8.5 $74.40
12/30/20224,750,000 shares $352.78 million -5.6%6.2%8.1 $74.27
12/15/20225,030,000 shares $363.92 million -15.2%6.6%8.6 $72.35
11/30/20225,930,000 shares $438.17 million +2.4%7.7%9.5 $73.89
11/15/20225,790,000 shares $415.61 million +7.6%7.5%9.4 $71.78
Here’s the stock symbol I’ve promised (Ad)

Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel

Get the stock name and ticker symbol free of charge today
10/31/20225,380,000 shares $360.46 million +9.4%N/A9.4 $67.00
10/15/20224,920,000 shares $298.99 million +0.6%N/A8.4 $60.77
9/30/20224,890,000 shares $291.30 million +1.0%N/A8.3 $59.57
9/15/20224,840,000 shares $297.71 million -7.5%N/A8 $61.51
8/31/20225,230,000 shares $309.56 million +0.8%N/A8.3 $59.19
8/15/20225,190,000 shares $350.53 million +3.0%N/A8.3 $67.54
7/31/20225,040,000 shares $295.80 million +1.4%6.7%7.1 $58.69
7/15/20224,970,000 shares $280.01 million +5.1%6.6%6.1 $56.34
6/30/20224,730,000 shares $265.54 million +2.2%6.3%5.4 $56.14
6/15/20224,630,000 shares $257.34 million +2.7%6.2%5.3 $55.58
5/31/20224,510,000 shares $300.37 million +2.5%N/A5.4 $66.60
5/15/20224,400,000 shares $279.80 million +30.6%N/A5.2 $63.59
4/30/20223,370,000 shares $223.16 million -13.8%N/A4.3 $66.22
4/15/20223,910,000 shares $303.03 million +51.0%N/A5.5 $77.50
3/31/20222,590,000 shares $191.09 million +14.6%N/A4.4 $73.78
3/15/20222,260,000 shares $148.91 million +137.5%N/A4.2 $65.89
2/28/2022951,500 shares $66.91 million -25.7%N/A1.7 $70.32
2/15/20221,280,000 shares $88.64 million +34.1%N/A2.4 $69.25
1/31/2022954,600 shares $63.70 million +27.8%N/A1.8 $66.73
1/15/2022747,000 shares $54.87 million -19.8%N/A1.5 $73.45
12/31/2021931,300 shares $67.24 million -9.6%N/A1.9 $72.20
12/15/20211,030,000 shares $68.95 million +27.4%N/A2.1 $66.94
11/30/2021808,400 shares $50.62 million +3.4%N/A1.8 $62.62
11/15/2021782,200 shares $55.37 million -31.4%N/A1.7 $70.79
10/29/20211,140,000 shares $87.97 million -14.9%N/A2.7 $77.17
10/15/20211,340,000 shares $102.42 million +14.5%1.7%3.2 $76.43
9/30/20211,170,000 shares $89.65 million +1.7%1.5%2.7 $76.62
9/15/20211,150,000 shares $93.29 million +0.9%1.5%2.5 $81.12
8/31/20211,140,000 shares $93.02 million -1.7%1.5%2.7 $81.60
8/13/20211,160,000 shares $88.64 million -17.1%1.5%2.9 $76.41

GMED Short Interest - Frequently Asked Questions

Short interest is the volume of Globus Medical shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 6,886,644 shares of GMED short. 6.22% of Globus Medical's shares are currently sold short. Learn More on Globus Medical's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GMED shares currently have a short interest ratio of 4.9. Learn More on Globus Medical's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.22% of Globus Medical's floating shares are currently sold short.

Globus Medical saw a drop in short interest during the month of July. As of July 31st, there was short interest totaling 6,886,644 shares, a drop of 2.6% from the previous total of 7,069,160 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

6.22% of Globus Medical's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare equipment" compare to Globus Medical: GE HealthCare Technologies Inc. (4.31%), DexCom, Inc. (4.66%), ResMed Inc. (10.88%), Koninklijke Philips N.V. (0.29%), STERIS plc (3.28%), Zimmer Biomet Holdings, Inc. (5.94%), Baxter International Inc. (6.33%), Penumbra, Inc. (4.80%), Smith & Nephew SNATS, Inc. (1.21%), Glaukos Corporation (6.53%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.50 billion), Invesco QQQ ($50.36 billion), iShares Russell 2000 ETF ($21.20 billion), Western Digital Corporation ($13.40 billion), SPDR S&P Biotech ETF ($11.59 billion), Nebius Group N.V. ($11.46 billion), iShares 20+ Year Treasury Bond ETF ($7.84 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($7.51 billion), iShares Semiconductor ETF ($6.37 billion), and Financial Select Sector SPDR Fund ($6.34 billion). View all of the most shorted stocks.

Short selling GMED is an investing strategy that aims to generate trading profit from Globus Medical as its price is falling. GMED shares are trading up $0.33 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Globus Medical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GMED, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GMED, twice per month. The most recent reporting period available is July, 31 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like GMED:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for NYSE:GMED is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 8/11/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Iran War: What Happened at 1:11 P.M. Outside D.C.?
A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 t...
Banyan Hill Publishing | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
The government values gold at $42. It's really $4,800.
The U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...
Golden Portfolio | Sponsoredtc pixel
A $2 trillion fund just sounded the alarm
Norway's roughly $2 trillion sovereign wealth fund holds massive stakes in Nvidia, Apple and SpaceX. Its CEO n...
The Oxford Club | Sponsoredtc pixel